Get the latest Science News and Discoveries

Cystic fibrosis: School-aged children benefit from triple combination therapy - EurekAlert

Cystic fibrosis is a hereditary disease that so far has been incurable. Those affected have thick, viscous mucus secretions in their lungs, and lung function diminishes steadily over time. Today, triple combination therapy makes it possible to address the root causes of the defect underlying the disease. This form of treatment was recently approved for children in addition to adults. A recent observational study led by Charité – Universitätsmedizin Berlin shows that the new treatment significantly improves the health status of school-aged children with cystic fibrosis. The results have been published in the European Respiratory Journal.*

None

Get the Android app